SCOPUS 정보 검색 플랫폼

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 872, Issue 1-2, 2008, Pages 43-50

Determination of rivaroxaban - a novel, oral, direct Factor Xa inhibitor - in human plasma by high-performance liquid chromatography-tandem mass spectrometry

(1) Rohde, G a

a BAYER PHARMA AG (Germany)

Author keywords

Factor Xa inhibitor; Rivaroxaban

Indexed keywords

BODY FLUIDS; CENTRIFUGATION; CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETERS; MASS SPECTROMETRY; METHANOL; PLASMA (HUMAN); PLASMAS; SPECTROMETERS; SPECTROMETRY; SPECTRUM ANALYSIS; STANDARDS; WEIGHT CONTROL;

CLINICAL STUDIES; FACTOR XA; FACTOR XA INHIBITOR; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; HPLC-MS/MS; HUMAN PLASMAS; INTER-ASSAY ACCURACY; INTER-ASSAY PRECISION; INTERNAL STANDARD; PLASMA PROTEINS; RIVAROXABAN; WORKING RANGE;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

METHANOL; RIVAROXABAN;

ARTICLE; CENTRIFUGATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRECIPITATION; PRIORITY JOURNAL; SUPERNATANT; TANDEM MASS SPECTROMETRY;

CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FACTOR XA; HUMANS; MORPHOLINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SERINE PROTEINASE INHIBITORS; TANDEM MASS SPECTROMETRY; THIOPHENES;

EID: 49849103069 PISSN: 15700232 EISSN: None Source Type: Journal
DOI: 10.1016/j.jchromb.2008.07.015 Document Type: Article

Times cited : (129)

References (15)

1
- 0141498160
- Mann K.G., Brummel K., and Butenas S. J. Thromb. Haemost. 1 (2003) 1504
- (2003) J. Thromb. Haemost. , vol.1 , pp. 1504
- Mann, K.G.¹ Brummel, K.² Butenas, S.³

2
- 24944536065
- Roehrig S., Straub A., Pohlmann J., Lampe T., Pernerstorfer J., and Schlemmer K.H. J. Med. Chem. 48 (2005) 5900
- (2005) J. Med. Chem. , vol.48 , pp. 5900
- Roehrig, S.¹ Straub, A.² Pohlmann, J.³ Lampe, T.⁴ Pernerstorfer, J.⁵ Schlemmer, K.H.⁶

3
- 49849105459
- abstract PO079
- Perzborn E., Strassburger J., Wilmen A., Lampe T., Pernerstorfer P., Pohlmann J., et al. Pathophysiol. Haemost. Thromb. 33 (2004) abstract PO079
- (2004) Pathophysiol. Haemost. Thromb. , vol.33
- Perzborn, E.¹ Strassburger, J.² Wilmen, A.³ Lampe, T.⁴ Pernerstorfer, P.⁵ Pohlmann, J.⁶

4
- 33947322997
- Biemond B.J., Perzborn E., Friederich P.W., Levi M., Buetehorn U., and Buller H.R. Thromb. Haemost. 97 (2007) 471
- (2007) Thromb. Haemost. , vol.97 , pp. 471
- Biemond, B.J.¹ Perzborn, E.² Friederich, P.W.³ Levi, M.⁴ Buetehorn, U.⁵ Buller, H.R.⁶

5
- 25844525489
- Kubitza D., Becka M., Voith B., Zuehlsdorf M., and Wensing G. Clin. Pharmacol. Ther. 78 (2005) 412
- (2005) Clin. Pharmacol. Ther. , vol.78 , pp. 412
- Kubitza, D.¹ Becka, M.² Voith, B.³ Zuehlsdorf, M.⁴ Wensing, G.⁵

6
- 29144518504
- Kubitza D., Becka M., Wensing G., Voith B., and Zuehlsdorf M. Eur. J. Clin. Pharmacol. 61 (2005) 873
- (2005) Eur. J. Clin. Pharmacol. , vol.61 , pp. 873
- Kubitza, D.¹ Becka, M.² Wensing, G.³ Voith, B.⁴ Zuehlsdorf, M.⁵

7
- 33644867218
- Eriksson B.I., Borris L., Dahl O.E., Haas S., Huisman M.V., Kakkar A.K., et al. J. Thromb. Haemost. 4 (2006) 121
- (2006) J. Thromb. Haemost. , vol.4 , pp. 121
- Eriksson, B.I.¹ Borris, L.² Dahl, O.E.³ Haas, S.⁴ Huisman, M.V.⁵ Kakkar, A.K.⁶

8
- 34249310268
- Turpie A.G. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 1238
- (2007) Arterioscler. Thromb. Vasc. Biol. , vol.27 , pp. 1238
- Turpie, A.G.¹

9
- 33751559902
- Eriksson B.I., Borris L.C., Dahl O.E., Haas S., Huisman M.V., Kakkar A.K., et al. Circulation 114 (2006) 2374
- (2006) Circulation , vol.114 , pp. 2374
- Eriksson, B.I.¹ Borris, L.C.² Dahl, O.E.³ Haas, S.⁴ Huisman, M.V.⁵ Kakkar, A.K.⁶

10
- 34447317298
- Agnelli G., Gallus A., Goldhaber S.Z., Haas S., Huisman M.V., Hull R.D., et al. Circulation 116 (2007) 180
- (2007) Circulation , vol.116 , pp. 180
- Agnelli, G.¹ Gallus, A.² Goldhaber, S.Z.³ Haas, S.⁴ Huisman, M.V.⁵ Hull, R.D.⁶

11
- 49849085197
- abstract O-S-006B
- Lassen M.R., Turpie A.G., Rosencher N., Borris L., Ageno W., Lieberman J.R., et al. J. Thromb. Haemost. 5 (2007) abstract O-S-006B
- (2007) J. Thromb. Haemost. , vol.5
- Lassen, M.R.¹ Turpie, A.G.² Rosencher, N.³ Borris, L.⁴ Ageno, W.⁵ Lieberman, J.R.⁶

12
- 49849105905
- U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) et al. Guidance for Industry, Bioanalytical Method Validation, 2001.
- U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) et al. Guidance for Industry, Bioanalytical Method Validation, 2001.

13
- 49849101693
- Commission of the European Communities/CPMP Working Party on Quality of Medicinal Products. Note for Guidance III/844/87-EN: Analytical Validation, 1989.
- Commission of the European Communities/CPMP Working Party on Quality of Medicinal Products. Note for Guidance III/844/87-EN: Analytical Validation, 1989.

14
- 34147181108
- abstract supplement
- Buller H.R. Eur. Heart J. 27 (2006) 761 abstract supplement
- (2006) Eur. Heart J. , vol.27 , pp. 761
- Buller, H.R.¹

15
- 49849083341
- Data on file at Bayer HealthCare AG.
- Data on file at Bayer HealthCare AG.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.